NCT01203267
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Pathologic Complete Response
Explore clinical trials studying Pathologic Complete Response. Study availability and eligibility vary by location and protocol.
92 public trials
30 recruiting studies
Pathologic Complete Response trial results
NCT00343720
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- Hopital de Jolimont Haine-Saint-Paul, Belgium
NCT00378222
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
Active, Not Recruiting
Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)
NCT02386670
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Depressive Disorder, +13 more
- Locations
-
- Baycrest Centre for Geriatric Care Toronto, Ontario, Canada
- Centre for Addiction and Mental Health Toronto, Ontario, Canada
- St. Michael's Hospital Toronto, Ontario, Canada
- Sunnybrook Heath Sciences Centre Toronto, Ontario, Canada
Active, Not Recruiting
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
Active, Not Recruiting
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
NCT03832569
- Conditions
- Disease Attributes, Disease Progression, Identified by NGS, PCR or IHC, +4 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Active, Not Recruiting
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986
- Conditions
- Adnexal Diseases, Advanced Ovarian Cancer, BRCA Mutation, +24 more
- Locations
-
- Clearview Cancer Institute Huntsville, Alabama, United States
- Providence Cancer Center Anchorage, Alaska, United States
- St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
Active, Not Recruiting
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
NCT04229979
- Conditions
- Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
- Locations
-
- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- UCLA Medical Hematology and Oncology Los Angeles, California, United States
- The Oncology Institute of Hope and Innovation Whittier, California, United States
- Colorado Blood Cancer Institute - SCRI - PPDS Denver, Colorado, United States
Active, Not Recruiting
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
NCT04335669
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Vejle Hospital Vejle, Region Syd, Denmark
- Aalborg Universitetshospita Aalborg, Denmark
- Rigshospitalet Copenhagen, Denmark
- Sydvestjysk Sygehus Esbjerg, Denmark
Active, Not Recruiting
Feasibility of the Maastro Applicator in Rectal Cancer
NCT06087718
- Conditions
- Brachytherapy, Colorectal Neoplasms, Complete Response, +23 more
- Locations
-
- Maastro Maastricht, Limburg, Netherlands